894 research outputs found

    Results of the Austrian-Ceylonese hydrobiological mission 1970 of the 1st Zoological Institute of the University of Vienna (Austria) and the Department of Zoology of the University of Ceylon Vidyalankara Campus, Kelaniya. Pt. 13. Some remarkable ripicol insects of the Ceylonese fauna

    Get PDF
    New Ceylonese records namely, Euscelimena gavialis (Sauss.), Paranemobius pictus Sauss. and semiaquatic cockroaches of the genus Rhabdoblatta were found in the collection of Saltatorid and Dictyopterid insects

    FATIGUE TESTS ON THE OLD STRINGERS OF THE RAILWAY BRIDGES

    Get PDF
    Both elements in one of the sections of the stringers of the Southern Railway Bridge in Budapest were replaced. With the use of the removed stringers, as well as those of another railway bridge closed to traffic, laboratory experiments were conducted. In their course fatigue test of the basic steel material was performed by the step method using specimens cut out of different places of the longitudinal girder. which was followed by the fatigue test performed on one of the complete on-stringers of the Southern Railway Bridge. The results are reported in this paper

    Effectiveness of a Smoking Cessation Intervention for Methadone-Maintained Women: A Comparison of Pregnant and Parenting Women

    Get PDF
    Women in substance abuse programs have high rates of smoking. Pregnancy represents a unique opportunity for intervention, but few data exist to guide tailoring of effective interventions. In this study, 44 pregnant and 47 nonpregnant opioid-dependent women enrolled in comprehensive substance abuse treatment received a 6-week smoking cessation intervention based on the 5A's counseling model. The number of daily cigarettes decreased by 49% for pregnant patients and 32% for nonpregnant patients at the 3-month followup. Length of time in substance abuse treatment did not correlate with smoking cessation or reduction for either group. Factors predicting reduction of cigarette smoking differed for pregnant versus nonpregnant patients. For pregnant patients, lower levels of nicotine use prior to intervention and self-reported cigarette cravings predicted successful reduction in smoking. For nonpregnant patients, lower affiliative attachment to cigarettes, reliance on cigarettes for cognitive enhancement, and greater sense of control predicted more successful outcomes

    Skylab 4 visual observations project report

    Get PDF
    The Skylab 4 Visual Observations Project was undertaken to determine the ways in which man can contribute to future earth-orbital observational programs. The premission training consisted of 17 hours of lectures by scientists representing 16 disciplines and provided the crewmen information on observational and photographic procedures and the scientific significance of this information. During the Skylab 4 mission, more than 850 observations and 2000 photographs with the 70-millimeter Hasselblad and 35-millimeter Nikon cameras were obtained for many investigative areas. Preliminary results of the project indicate that man can obtain new and unique information to support satellite earth-survey programs because of his inherent capability to make selective observations, to integrate the information, and to record the data by describing and photographing the observational sites

    Quasi-optimal Discontinuous Galerkin discretisations of the pp-Dirichlet problem

    Full text link
    The classical arguments employed when obtaining error estimates of Finite Element (FE) discretisations of elliptic problems lead to more restrictive assumptions on the regularity of the exact solution when applied to non-conforming methods. The so-called minimal regularity estimates available in the literature relax some of these assumptions, but are not truly of -minimal regularity-, since a data oscillation term appears in the error estimate. Employing an approach based on a smoothing operator, we derive for the first time error estimates for Discontinuous Galerkin (DG) type discretisations of non-linear problems with (p,δ)(p,\delta)-structure that only assume the natural W1,pW^{1,p}-regularity of the exact solution, and which do not contain any oscillation terms

    Models of Outdoor Recreational Travel

    Get PDF
    The purpose of this investigation was to evaluate models of travel flow from population centers throughout the United States to outdoor recreational areas in Kentucky. Data were obtained by means of a license-plate, origin-destination survey at 160 sites within 42 recreational areas and by means of a continuous vehicle counting program at eight of these sites. Attempts to simulate distributed travel flows concentrated on various single-equation models, a cross-classification model, and gravity and intervening opportunities models. The cross-classification model was found to be an acceptable means for simulating and predicting outdoor recreational travel flows and was decidedly superior to the other models. From the cross-classification model, per capita distributed flows were found to (1) decrease at a decreasing rate with increasing population of the origin zone, (2) increase at a variable rate with increasing attraction of tbe recreational area, and (3) decrease at a decreasing rate with increasing distance. The intervening opportunities model was found to be unacceptable as a distribution model since it could not effectively accommodate the widely differing sizes of the 42 recreational areas. The gravity model, on the other hand, was quite effective in distributing actual productions and attractions. Problems associated with tbe gravity model were limited to difficulties in accurately estimating trip productions and attractions in the trip generation phase of analysis

    Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines

    Get PDF
    Background Authors of clinical practice guidelines (CPGs) disclose financial conflicts of interest (FCOIs) to promote transparency ethics. Typically, they do so on standard declaration forms containing generic open-ended questions on FCOIs. Yet, the literature is scant on the format and effect of alternative disclosure forms. Does supplementing a standard form with subsequent detailed disclosure forms tailored to the context of the CPG improve the yield or accuracy of FCOIs declarations? Methods For an international CPG in gastroenterology on the endoscopic surveillance for colorectal neoplasia in inflammatory bowel disease, we compared the use of a standard FCOIs disclosure form with a contextual FCOIs disclosure form that detailed commercial relations related to the CPG topic. This included manufacturers of endoscopes, endoscopy equipment and accessories. Participants completed the generic form early, and the supplementary contextual form six months later. We then compared the FCOI disclosures obtained. Findings 26 participants provided FCOIs disclosures using both disclosure forms. We found discrepancies regarding (1) the disclosure of FCOIs (presence/absence), and (2) the listing of financial entities. While the number of participants who disclosed a FCOI remained the same (30.8%) using the two forms, disclosures were not from the same individuals: two additional participants disclosed a FCOI, whereas two participants withdrew previous disclosures. Among those who reported a FCOI in either form, we noted inconsistencies in disclosures for 70% of the participants. This included changes in FCOIs disclosure status or modifications of "their commercial relations". Discussion Accurate reporting of FCOIs advances the transparency and ethical integrity of CPGs. Our experience suggests that a contextual FCOIs disclosure form tailored to content of the CPG with narrow, detailed questions provides supplementary, more complete FCOIs declarations than generic forms alone. The finding raises challenges on how forms are best written and formatted, optimally timed, and more effectively processed with sensitivity to professional behaviour, so as to heighten transparency

    Antiplatelet Therapy Changes for Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From the TRANSLATE-ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome) Study

    Get PDF
    BACKGROUND: Guidelines recommend P2Y12 inhibitor therapy for 1 year after myocardial infarction (MI), yet little guidance is provided on antiplatelet management for patients with recurrent ischemic events during that year. We describe changes in P2Y12 inhibitor type among patients with recurrent ischemic events in the first year after MI. METHODS AND RESULTS: The TRANSLATE-ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome) study enrolled 12 365 patients with MI treated with percutaneous coronary intervention. We examined whether P2Y12 inhibitor choice changed among patients with recurrent MI, stent thrombosis, and/or unplanned revascularization during the first year after MI, and modeled factors associated with P2Y12 inhibitor intensification (changing clopidogrel to prasugrel or ticagrelor). In the first year after MI, 1414 patients (11%) had a total of 1740 recurrent ischemic events (771 recurrent MIs, 969 unplanned revascularizations, and 165 stent thromboses). Median time to the first recurrent ischemic event was 154 days (25th-75th percentiles, 55-287 days). Of those with recurrent ischemic events, 101 of 1092 (9.3%) occurring in clopidogrel-treated patients led to P2Y12 inhibitor intensification. Recurrent events involving stent thrombosis or MI were the strongest factors associated with P2Y12 inhibitor intensification, yet only 40% of patients with stent thrombosis and 14% of patients with recurrent MI had P2Y12 inhibitor intensification. Increasing age and longer time from the index MI were associated with lower likelihood for intensification. CONCLUSIONS: Few patients after MI with a recurrent ischemic event who were taking clopidogrel switched to a more potent P2Y12 inhibitor, even after stent thrombosis events. Specific guidance is needed for patients who have recurrent ischemic events, particularly when closely spaced. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT01088503
    corecore